Thymosin β4-Enhancing Therapeutic Efficacy of Human Adipose-Derived Stem Cells in Mouse Ischemic Hindlimb Model.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
21 Mar 2020
Historique:
received: 02 03 2020
revised: 19 03 2020
accepted: 19 03 2020
entrez: 5 4 2020
pubmed: 5 4 2020
medline: 14 1 2021
Statut: epublish

Résumé

Thymosin β4 (Tβ4) is a G-actin sequestering protein that contributes to diverse cellular activities, such as migration and angiogenesis. In this study, the beneficial effects of combined cell therapy with Tβ4 and human adipose-derived stem cells (hASCs) in a mouse ischemic hindlimb model were investigated. We observed that exogenous treatment with Tβ4 enhanced endogenous

Identifiants

pubmed: 32245208
pii: ijms21062166
doi: 10.3390/ijms21062166
pmc: PMC7139370
pii:
doi:

Substances chimiques

thymosin beta(4) 549LM7U24W
Thymosin 61512-21-8
Proto-Oncogene Proteins c-akt EC 2.7.11.1
TOR Serine-Threonine Kinases EC 2.7.11.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research Foundation of Korea
ID : NRF-2016R1A6A3A11930414
Organisme : National Research Foundation of Korea
ID : NRF-2019R1I1A1A01056103

Références

J Cell Mol Med. 2014 Dec;18(12):2417-24
pubmed: 25284727
Nature. 2004 Nov 25;432(7016):466-72
pubmed: 15565145
Biochem Biophys Res Commun. 2014 Sep 26;452(3):858-64
pubmed: 25218472
Proc Natl Acad Sci U S A. 1981 Feb;78(2):1162-6
pubmed: 6940133
Expert Opin Biol Ther. 2018 Jul;18(sup1):177-184
pubmed: 30063851
J Cell Physiol. 2011 Nov;226(11):2798-806
pubmed: 21935929
Nat Commun. 2010 Jul 27;1:46
pubmed: 20975697
J Vasc Surg. 2017 May;65(5):1483-1492
pubmed: 27514438
Mol Med Rep. 2018 Aug;18(2):2314-2320
pubmed: 29956769
Int J Biochem Cell Biol. 2001 Mar;33(3):205-20
pubmed: 11311852
Angiogenesis. 1999;3(2):125-35
pubmed: 14517430
Circulation. 2013 Sep 10;128(11 Suppl 1):S32-41
pubmed: 24030419
Expert Opin Biol Ther. 2018 Jul;18(sup1):105-110
pubmed: 30063846
Oncogene. 2007 Apr 26;26(19):2781-90
pubmed: 17072345
Peptides. 2009 Oct;30(10):1822-32
pubmed: 19631707
Stem Cells. 2009 Aug;27(8):1976-86
pubmed: 19544425
Exp Cell Res. 2013 Oct 15;319(17):2526-34
pubmed: 23712052
Cell Physiol Biochem. 2007;20(6):867-76
pubmed: 17982269
Int J Mol Sci. 2015 May 08;16(5):10624-35
pubmed: 26006229
Eur J Histochem. 2011;55(3):e25
pubmed: 22073372
J Cell Mol Med. 2018 Feb;22(2):746-754
pubmed: 29214727
Sci Rep. 2018 Dec 4;8(1):17458
pubmed: 30514962
J Orthop Res. 2010 Jan;28(1):131-8
pubmed: 19637215
FASEB J. 2004 Feb;18(2):385-7
pubmed: 14657002
Stem Cells Int. 2018 Dec 13;2018:7537589
pubmed: 30651736
Cell. 2003 Feb 21;112(4):453-65
pubmed: 12600310
PLoS One. 2016 Feb 03;11(2):e0147853
pubmed: 26840069
Trends Cardiovasc Med. 2008 Aug;18(6):205-10
pubmed: 19185810
J Cardiovasc Pharmacol. 2009 Mar;53(3):209-14
pubmed: 19247195
Pharmacol Ther. 2001 Aug;91(2):105-14
pubmed: 11728604
Int J Cardiol. 2015 Oct 15;197:33-43
pubmed: 26113473
Neurosci Res. 2019 Oct;147:1-8
pubmed: 30326249
Kidney Int. 2013 Dec;84(6):1166-75
pubmed: 23739235
Int J Mol Med. 2014 Sep;34(3):816-21
pubmed: 24993983
Amino Acids. 2016 Jan;48(1):117-27
pubmed: 26276576
Nature. 2007 Jan 11;445(7124):177-82
pubmed: 17108969
J Cell Sci. 1995 Dec;108 ( Pt 12):3685-94
pubmed: 8719875
Nat Commun. 2013;4:2081
pubmed: 23820300
Invest Ophthalmol Vis Sci. 2007 Jan;48(1):27-33
pubmed: 17197512
Tissue Eng Part A. 2017 Jan;23(1-2):1-11
pubmed: 27676105
Stem Cell Res Ther. 2019 May 20;10(1):133
pubmed: 31109374
Expert Opin Biol Ther. 2015;15 Suppl 1:S163-74
pubmed: 26094634
Am J Respir Crit Care Med. 2011 Jan 15;183(2):215-25
pubmed: 20709815

Auteurs

Jong-Ho Kim (JH)

Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul 02841, Korea.

I-Rang Lim (IR)

Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul 02841, Korea.

Chi-Yeon Park (CY)

Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul 02841, Korea.

Hyung Joon Joo (HJ)

Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul 02841, Korea.

Ji-Min Noh (JM)

Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul 02841, Korea.

Seung-Cheol Choi (SC)

Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul 02841, Korea.

Soon Jun Hong (SJ)

Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul 02841, Korea.

Do-Sun Lim (DS)

Department of Cardiology, Cardiovascular Center, Korea University College of Medicine, Seoul 02841, Korea.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH